A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations - The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol.
Pradeesh SivapalanMia MobergJosefin EklöfJulie JannerJørgen VestboRasmus Rude LaubAndrea BrowatzkiKarin ArmbrusterJon Torgny WilckeNiels SeersholmUlla Møller WeinreichIngrid Louise TitlestadHelle Frost AndreassenCharlotte Suppli UlrikUffe BødtgerThyge Lynghøj NielsenEjvind Frausing HansenJens Ulrik Stæhr JensenPublished in: BMC pulmonary medicine (2017)
Clinicaltrials.gov, NCT02857842 , 02-august-2016. Clinicaltrialregister.eu: Classification Code: 10,010,953, 02-marts-2016.